Equity ka Funda by SMC

🆓📈 Join Us for a Free Webinar to “How to Master Trading with Math & Probability” 📊 🕖 Date & Time: 4th Aug 2026, 7:00 PM onwards 📲 Register Now: https://tinyurl.com/3d4c6nxc 🎁 Key Benefits of the Webinar: 👉 Replace emotional trading with data-driven decisions 👉 Learn mathematical techniques used by professional traders 👉 Understand risk-reward, win rate, and probability concepts 👉 How to develop disciplined trading rules 👉 Interactive Q&A session 🎤 Speaker: Nitin Murarka, Head Research (Derivatives), SMC Global

🆓📈 Join Us for a Free Webinar to “How to Master Trading with Math & Probability” 📊 🕖 Date & Time: 4th Aug 2026, 7:00 PM onwards 📲 Register Now: https://tinyurl.com/3d4c6nxc 🎁 Key Benefits of the Webinar: 👉 Replace emotional trading with data-driven decisions 👉 Learn mathematical techniques used by professional traders 👉 Understand risk-reward, win rate, and probability concepts 👉 How to develop disciplined trading rules 👉 Interactive Q&A session 🎤 Speaker: Nitin Murarka, Head Research (Derivatives), SMC Global

🇯🇵 Bank of Japan (BOJ) Policy Decision & July 2026 Economic Outlook 📌 Key Highlights ·         Interest Rate Kept at 1.0%: The BOJ voted 8–1 to hold its benchmark rate at around 1.0%. Board member Hajime Takata dissented, proposing an immediate rate hike to 1.25%. ·         Tightening Path Maintained: The Bank officially reiterated that it will continue adjusting monetary accommodation (raising interest rates) if economic activity and inflation track its projections. ·         Growth Underpinned by AI Demand: While higher Middle East crude oil prices exert drag, economic activity remains supported by global AI infrastructure demand, fiscal measures, and accommodative conditions. ·         Core Inflation Projected Above 2.0%: Core CPI is expected to accelerate above 2.0% in H2 FY2026, driven by wage pass-through, high energy input costs, rising semiconductor prices, and yen depreciation. 💡 Bottom Line ·         Summary: The BOJ paused at 1.0% to evaluate global energy risks, but the 8–1 vote and explicit forward guidance signal that Japan's rate-hiking cycle remains firmly active. ·         💵 Rate Hike Outlook: With core inflation projected above 2.0% in H2 FY2026 and a hawkish dissent pushing for 1.25%, market expectations point toward additional rate hikes before year-end. ·         🌐 Yen Carry Trade & Global Markets: Pausing at 1.0% prevents an abrupt unwinding of Yen carry trades in the short term. However, as the yield gap between Japan and global central banks continues to narrow, long-term carry trade incentives are shrinking—gradually shifting capital flows back toward the Yen.

🇪🇺 Eurostat Flash Estimate: Eurozone GDP Rebounds +0.4% in Q2 2026 📌 Key Highlights ·         Eurozone GDP Rebounds: Seasonally adjusted Euro Area GDP grew +0.4% QoQ in Q2 2026 (up from 0.0% in Q1). Year-on-year growth rose to +1.0% YoY (up from +0.5% in Q1). ·         Wider EU Expands: The broader 27-nation European Union economy grew +0.5% QoQ (up from +0.1% in Q1) and +1.2% YoY (up from +0.8% in Q1). 💡 Bottom Line ·         📈 Stock & Bond Impact: The rebound in official growth figures provides fundamental support for European equity markets, while keeping European government bond yields grounded near current levels. ·         💳 Consumer / Household Health Check: Steady macroeconomic output across major Member States helps maintain broader employment stability and real household income across the region.

🇺🇸 US Q2 2026 GDP Update: Real Growth Cools to 1.5%, But Private Demand Accelerates 📌 Key Highlights ·         Headline Real GDP Moderates: US Real GDP grew at an annualized rate of 1.5% in Q2 2026, slowing from 2.1% in Q1. ·         Core Private Demand Surges: Stripping out volatile trade, government, and inventories, Real Final Sales to Private Domestic Purchasers jumped +3.9% (up from +1.7% in Q1), showing resilient consumer and business activity. ·         Trade & Inventory Drag: The headline slowdown was heavily driven by a decrease in private inventory investment (-0.67 percentage points) and a surge in imports (which subtract from GDP). ·         Broad Prices Accelerate: The broad GDP Price Deflator rose +6.3% annualized, while quarterly Core PCE inflation moderated to +3.4% (down from +4.4% in Q1). 💡 Bottom Line ·         Summary: The headline 1.5% growth figure masks a very strong US private economy (+3.9% domestic sales) that was mechanically pulled down by higher import volumes and wholesale inventory destocking. ·         💵 Fed Rate Cut Expectations: High core private demand (+3.9%) and an elevated 6.3% broad GDP deflator give the Fed reason to stay cautious, delaying immediate rate cuts despite the cooler headline growth. ·         📈 Stock & Bond Impact: Markets face a mixed signal—resilient business equipment investment and consumer spending support corporate earnings, but persistent nominal price growth keeps bond yields elevated. ·         💳 Consumer / Household Health Check: Consumer spending accelerated in Q2 across both goods and services, confirming that household demand remains solid despite higher borrowing costs.

💊 Torrent Pharmaceuticals Ltd – Q1 FY27 Results 🏥🧪 Strong revenue growth led by JB Pharma integration; operating performance remains robust while PAT is impacted by merger-related costs. 📊 Q1 FY27 Financial Highlights (Consolidated) 🔹 Revenue: ₹4,921 Cr ⬆️ 54.8% YoY (vs ₹3,178 Cr) — driven by JB Pharma consolidation & base business growth. 🔹 EBITDA: ₹1,664 Cr ⬆️ 61% YoY (before exceptional items) 📈 EBITDA Margin: Expanded to 33.8% (vs 32.5% in Q1 FY26) 🔹 PAT: ₹566 Cr ⬆️ 3.3% YoY (vs ₹548 Cr) 🔹 Gross Margin: Improved to 76.4% (vs 75.6% in Q1 FY26) on favorable product mix & pricing. ⚠️ Note on PAT: Bottom-line growth remained subdued due to higher depreciation, finance costs post-acquisition, and ₹21 Cr in exceptional expenses (merger costs & inventory write-off). 🌍 Geographic & Unit Performance 🇮🇳 India Business (Record Quarter): • Revenue: ₹2,157 Cr (⬆️ 19% YoY vs IPM growth of 12%) • Milestones: Became the #1 player in the cardiac therapy segment; Generic Semaglutide achieved a 36% market share. 🇺🇸 United States: • Revenue: ₹418 Cr (⬆️ 36% YoY) — driven by new launches & one-time opportunities. 🇧🇷 Brazil: • Revenue: ₹277 Cr (⬆️ 27% YoY) 🇩🇪 Germany: • Revenue: Up 3% YoY despite temporary supply disruptions. 🤝 JB Pharma Contribution: • Revenue: ₹1,201 Cr (⬆️ 10% YoY) • Operating EBITDA: ₹424 Cr (⬆️ 34% YoY) | Margin: 35.3% 💡 Management Commentary • Domestic Dominance: Record organic growth in India backed by chronic therapy leadership and consistent IPM outperformance. • Integration Progress: Strong margin accretion from the JB Pharma portfolio strengthens overall operating profile.

🇺🇸 US PCE Inflation Update (June 2026): Monthly Prices Drop as Consumer Spending Holds Up 📌 Key Highlights ·         Headline Inflation Dips: The PCE Price Index fell -0.1% MoM in June (down from +0.5% in May), bringing headline annual inflation to 3.7% YoY. ·         Core PCE Cools to +0.1%: Core PCE (excluding volatile food and energy) rose just +0.1% MoM (down from +0.3% in May), pulling the year-over-year rate to 3.3% YoY. ·         Real Spending Stays Strong: Inflation-adjusted consumer spending (Real PCE) rose +0.4% MoM, showing US households are still actively spending, particularly on services. ·         Income & Saving: Personal income grew +0.2% MoM, while the personal saving rate remained subdued at 2.7%.   💡 Bottom Line ·         Summary: June data delivers a rare double win—monthly inflation took a step back while real consumer spending remained strong. ·         💵 Fed Rate Cut Expectations: A tame +0.1% monthly core PCE print is welcome news for markets. It strengthens the argument for Fed easing if monthly numbers stay near this pace. ·         📈 Stock & Bond Impact: Softening monthly inflation combined with steady +0.4% real spending supports a "soft landing" narrative, providing a positive backdrop for broad asset markets. ·         💳 Consumer Health Check: While income growth (+0.2%) is keeping pace with inflation, a low 2.7% saving rate signals that household cash buffers are thin, making future wage trends vital to watch.

🏦 Bank of England Holds Interest Rates at 3.75% Amid Middle East Energy Shock 📌 Key Highlights 6–3 Hawkish Vote Split: The MPC voted by a majority to keep the Bank Rate at 3.75%, but 3 members dissented in favor of a 25 bps hike to 4.0%. Divergent Inflation Forces: Headline CPI cooled to 2.6%, but higher energy costs (Brent ~$84/bbl, UK Gas 136p/therm) are projected to drive inflation back up later this year. Second-Round Risk Focus: While direct energy price spikes are looked through, the Bank is closely guarding against wage-price "second-round" persistence. Domestic Slack vs. External Shocks: Easing labor market conditions, slowing wage growth, and already-tightened financial conditions are actively pulling inflation down. 🎙 Key Member Commentary Andrew Bailey (BoE Governor) — Dovish Hold: "Holding Bank Rate is appropriate as global conditions look to be more uncertain and inflationary, while domestic conditions are on balance more benign..." Huw Pill & Dissenters — Hawkish Hike: "I remain concerned about more insidious second-round effects driven by catch-up dynamics in wage and price setting." 💡 Bottom Line Policy on Pause: The BoE is maintaining a strict "wait-and-see" insurance stance. Market Outlook: Rate cuts are effectively frozen until late 2026/2027. Any persistent energy price transmission or wage acceleration could force the majority to pivot toward a rate hike.

🔥 Tata Steel Ltd – Q1 FY27 Results 🏗⚙️ Profitability improves on stronger realizations, India business remains resilient; Europe continues to face challenges. 📊 Q1 FY27 Financial Highlights (Consolidated) YoY Performance (vs Q1 FY26): 🔹 Revenue: ₹60,794 Cr ⬆️ 14.3% (vs ₹53,178 Cr) 🔹 EBITDA: ₹9,370 Cr ⬆️ 25.3% (vs ₹7,480 Cr) 🔹 PAT: ₹2,385 Cr ⬆️ 18.8% (vs ₹2,007 Cr) 🔹 EBITDA / Tonne: ₹12,898 (supported by better global steel realizations) QoQ Performance (vs Q4 FY26): 🔻 Revenue: Down 3.9% (₹63,270 Cr → ₹60,794 Cr) due to seasonal delivery dips in India. 🔻 EBITDA: Down 5.9% (₹9,953 Cr → ₹9,370 Cr) 🔻 PAT: Down 19.6% (₹2,965 Cr → ₹2,385 Cr) 📉 EBITDA Margin: Moderated slightly to 15.4% (vs 15.7% in Q4 FY26) due to higher coking coal costs. 🌍 Geography-Wise Business Performance 🇮🇳 India (Primary Growth Driver): • EBITDA: ₹9,409 Cr • Deliveries: 5.17 MT (⬆️ 9% YoY) • EBITDA / Tonne: ₹18,198 (Sharp improvement via richer product mix & higher realizations) 🇳🇱 Tata Steel Netherlands: • EBITDA: ₹39 Cr (down sharply from ₹624 Cr in Q4 FY26 due to lower volumes & higher raw material costs) 🇬🇧 Tata Steel UK: • EBITDA Loss: Narrowed to ₹341 Cr (vs ₹591 Cr loss in Q4 FY26) on better realizations and lower substrate costs. 🛠 Key Developments & Expansion Plans ✅ NINL Expansion Approved: Board approved ₹33,873 Cr expansion for Neelachal Ispat Nigam Ltd. to boost capacity by 4.8 MTPA. ✅ Capacity Scale-Up: India steelmaking capacity has doubled to 27.4 MTPA (long-term target: >40 MTPA). ✅ Downstream Progress: Expansion ongoing at Kalinganagar (cold rolling, galvanizing, auto steel). 💡 Management Commentary & Strategy • Cost Optimization: Targetting ₹7,140 Cr in savings in FY27 through operational excellence & raw material efficiencies. • Decarbonization Roadmap: Transitioning UK operations to Electric Arc Furnace (EAF) and progressing sustainability initiatives in the Netherlands.

🚀 Mazagon Dock Shipbuilders Ltd (MDL) – Q1 FY27 Results 🚢⚓️ Revenue moderates on execution timing, margins remain resilient; healthy order book provides long-term visibility. 📊 Q1 FY27 Financial Highlights YoY Performance (vs Q1 FY26): 🔹 Revenue: ₹2,943 Cr ⬆️ 12.1% (vs ₹2,626 Cr) 🔹 EBITDA: ₹760 Cr ⬆️ 21.6% (vs ₹625 Cr) 🔹 PAT: ₹550 Cr ⬆️ 21.7% (vs ₹452 Cr) 🔹 Total Income: ₹3,256 Cr 🔹 Net Worth: ₹10,504 Cr QoQ Performance (vs Q4 FY26): 🔻 Revenue: Down 23.6% (₹3,850 Cr → ₹2,943 Cr) due to milestone-based execution. 🔻 EBITDA: Down 8.0% (₹826 Cr → ₹760 Cr) 🔻 PAT: Down 18.4% (₹674 Cr → ₹550 Cr) 📈 EBITDA Margin: Expanded to ~25.8% (vs ~21.5% in Q4 FY26) driven by a better execution mix and operating efficiency. 📋 Order Book & Execution Pipeline • Outstanding Order Book: ~₹18,218 Cr (as of 30 June 2026), offering strong revenue visibility. • Key Ongoing Projects: P15B Destroyers, P17A Stealth Frigates, Kalvari Class (P75) Submarines, Coast Guard vessels, and commercial marine projects. 🛠 Key Operational Developments ✅ Commissioned INS Taragiri (3rd P17A Stealth Frigate) on 03 April 2026. ✅ Delivered INS Mahendragiri (4th P17A Stealth Frigate) to the Indian Navy on 30 April 2026. ✅ Completed Second Reading Acceptance of INS Vagir (5th Kalvari-class submarine) in April 2026. ✅ Ongoing progress across Fast Patrol Vessels, Next-Gen Offshore Patrol Vessels, and Hybrid Multi-Purpose Vessels. 💡 Key Takeaways & Management Commentary • Debt-Free Balance Sheet: Strong financial positioning with high earnings quality. • Execution Capability: Able to build multiple submarines and warships concurrently. • Strategic Moat: High-value defence shipbuilding portfolio with robust indigenous manufacturing capabilities.